The Effect of Tranexamic Acid for EL2 after EVAR.

The Effect of Tranexamic Acid for Type2 Endoleak after Endovascular Abdomial Aortic Aneurysm Repair.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041180163

Enrollment

100

Registered

2019-03-29

Start date

2017-05-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal aortic aneurysm, iliac artery aneurysm Abdominal aortic aneurysm, iliac artery aneurysm

Interventions

Tranexamic acid group: tranexamic acid 250mg*3/day given on day1 to 30 after EVAR. Non Tranexamic acid group: Do not give any additional drugs.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo first bifurcated stent graft treatment for abdominal aortic aneurysm and iliac artery aneurysm at Aichi Medical University Hospital.

Exclusion criteria

Exclusion criteria: Patents who cannot take internal medicine.

Design outcomes

Primary

Measure	Time frame
Incidence of type2 endoleak	—

Secondary

Measure	Time frame
Changes in the size of aneurysms after EVAR	—

Contacts

Public ContactYUSUKE IMAEDA

Aichi Medical University Hospital

yusuke_ima@aichi-med-u.ac.jp+81-561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026